Tracers of radionuclide imaging
The radiopharmaceutical used is always selected in a case-specific manner. The radioisotopes most commonly used in cancer treatments are samarium, iodine, rhenium, lutetium and yttrium. The most common tracer in the imaging of cancer is fluorodeoxyglucose (FDG). The attending doctor together with the Chief Physician of Molecular Radiotherapy & Nuclear Medicine will determine the tracer that is optimal in any given situation.

Tracers available at Docrates Cancer Center
For example, FDG is a tracer which can not only be used in diagnosing of different types of cancers, but also in assessing their response to treatments. A tracer named PSMA, instead, is utilised in the overall staging of prostate cancer, and natriumfluoride (18F-NaF) is an excellent tracer for examining tumor staging to the bones.
PSMA is particularly sensitive in identifying post-operative or post-radiotherapy recurrences of prostate cancer at very low PSA-levels, as well as the dissemination of early prostate cancer to, for example, lymph nodes. PSMA imaging enables a more accurate diagnosis of prostate cancer, which means that the treatment can be better tailored using methods such as modern radiotherapy, promoting a good quality of life. Being able to accurately locate the cancer is also very important for the surgeon, among others, when planning a prostatectomy.
In addition to prostate cancer, the focus area in tracer diagnostics at Docrates is gynaecological cancers, particularly breast cancer.
Tracer production
Cyclotron
MAP Medical Technologies operates in the same building as Docrates Cancer Center. It has a cyclotron for the manufacture of radionuclide tracers and a GMP-level laboratory. There are only a handful of cancer hospitals in the world that can so optimally take advantage of the location of a cyclotron and imaging equipment (PET-CT, SPECT-CT) under the same roof.
Read more

Individually planned physiotherapy for cancer patients
Physiotherapy offers versatile methods and treatments that improve the quality of life and functional capacity of cancer patients during all...
Read more
The most aggressive cancers: pancreatic, lung and liver cancer show the fastest progression
The most aggressive cancers with the shortest life expectancy from diagnosis are pancreatic cancer, lung cancer and hepatocellular carcinoma or...
Read more
Meet the staff at Docrates Cancer Center – Introducing Chief Physician of Medical Oncology Tuomo Alanko
Tuomo Alanko, specialist in oncology and chemotherapy as well as clinical drug trials, has been a part of the skilled...
Read more
Docrates Cancer Center expands its hospital in Helsinki
June 26, 2023 | Docrates Cancer Center has decided to invest in a considerable expansion of its facilities in Jätkäsaari,...
Read moreWhy come to Docrates Cancer Center?
- Top cancer experts and effective treatments without delay.
- Individual care. You have your own care team - your doctor and your nurse.
- Front line cancer treatment. Latest medical technology combined with proven expertise in cancer care.
- Experience in treating international patients from over 60 countries. Multilingual personnel.
Contact us!
Mon-Thu 8:00-18:00, Fri 8:00-16:00
